FDA Investigator Rebecca K Olin

Rebecca K Olin has inspections in 6 countries as of 29 Sep 2023. Rebecca K Olin has collaborated with a combinined 4059 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
15
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Belgium, Italy, Germany, France, United States of America, Sweden
Co-Investigator(s):
Aikaterini Alexaki, Alan L Truong, Alicia M Mozzachio, Alla Kachko, PhD, Amir Alavi, Anastasia I Offordile, Andrey Sarafanov, PhD, Angela K Shea, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Ashley N Queen, PhD, Audrey Thereset Uy, Ava M Bowman, Barry Cherney, PhD, Benjamin J Smith, Brentley S Collins, Brian D Nicholson, Brian S Keefer, Bruce H Mccullough, Burnell M Henry, Carr Sharpe, Carrie A Hughes, Carrie Ann Plucinski, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Charles M Spyr, Chava Kimchi Sarfaty, PhD, Cheng H Yen, Christian D Lynch (CDL), Christina A Miller, Christina D Lynch, Christina J Sauder, PhD, Christina V Santos, Christopher J Adams, Christopher R Czajka, Constantin Y Philopoulos, Craig D Zagata, Cynthia Jim, CSO, Darla J Christopher, Dave Hafner, David A Paterson, David Doleski, David G Whitman, David J Hafner, David Perkins, Debra I Love, Debra J Bennett, Debra L Pagano, Destry M Sillivan, Deyaa Shaheen, Dino Feigelstock (DF), PhD, Dmitriy V Volokhov, PhD, Dr. Gang Wang, PhD, Dr. Willie F Vann, PhD, Edmund F Mrak, Jr, Edmund Fmrakjr S, Eileen A Liu, Eliezar Ramos, Ellen Huang, Emest F Bizjak, Emily J Orban, Enrico Joset Mangahis, Felice D'agnillo, PhD, Gene D Arcy, Grace Deneke, Hala L Selby, Haruhiko Murata, Helen B Ricalde, Humera Khan, Ifueko Osemwota, J David Doleski, Jacqueline Mdiaz Albertini, James C Maclaughlin, James E Keller, PhD, James M Mason, James R Evans, Jaqueline Diaz Albertini, Jason F Chancey, Jeanne M Morris, Jeffrey A Sommers, Jeffrey D Meng, Jennifer L Reed, Jennifer L Schmidt, Jennifer M Gogley, Jie He, Joan A Loreng, Joan Adamo, Joanne M Hajoway, Joey V Quitania, John F Cipollo, John M Mcinnis, Joseph George, Joyce A Rockwell, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Karyn M Campbell, Katherine E Jacobitz, Kathleen B Mihalik, Kathryn Carbone, MD, Kelly N Kerr, Kenneth M Gordon, Kevin P Foley, Kirsten L Vadheim, PhD, Kristen D Evans, Larry K Austin, Lata C Mathew, PhD, Laurie P Norwood, LCDR Debra Emerson, LCDR Margaret E Digennaro, Lequita M Mayhew, Leslie D Wagner, Lestine C Webb, Lewis K Antwi, Linda Thai, Lisa Feela, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, LT John M Mastalski, Marian E Major, PhD, Marian Majors, Marion Michaelis, Mariza M Jafary, Meisha R Sampson, Meisha Waters, Michael C Kennedy, PhD, Michael Curbag, Michael Gurbarg, Michael J Vardon, Michael Merchlinsky, Michael Shanks, MS, Michael T Cyrus, Michele L Forster, PhD, Michele L Glendenning, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Nancy Kirschbaum, PhD, Natalya M Ananyeva, Nawab A Siddiqui, Nayan J Patel, Nicholas F Lyons, Nicholas Obiri, PhD, Nicholas P Diorio, Nicole J Clausen, Nicole K Trudel, Nikisha M Bolden, Olga Simakova, Olno Folgolstock, Omotunde O Osunsanmi, Pankaj H Amin, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Peng Zhou, Phung Thien Nguyen, Pote Amin, Prabhu P Raju, Qiao Y Bobo, Ralph A Erickson, Ramon E Martinez, Randa Melhem, PhD, Rebecca E Dombrowski, Richard Heath Coats, Richard W Thornton, Robert B Shibuya, MD, Robert D Tollefsen, Robert M Barbosa, Robert Sausville, Robert W Jennings, Robin Levis, PhD, Roger F Zabinski, Roman Drews, PhD, Rona Leblanc, PhD, Rose M Ashley, Russ R Rivy, Russell K Riley, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah B Tanksley, Sarah M Meng, Sarah M Napier, Scott E Norris, Scott T Ballard, Sean R Bryd, Sheila Dreher Lesnick, Shirley J Berryman, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Solomon Yimam (SY), Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan Yu, Svetlana A Shestopal, Taichun Qin, PhD, Tammy L Chavis, Thuy T Nguyen, LCDR, Tina S Roecklein, Todd M Stankewicz, Travis S Bradley, Unnee Ranjan, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Vlada Matusovsky, Wei Wang, PhD, Xiao Wang, Yi Wang, PhD, Yiping Jia, Ze Peng, Zhihao Qiu (Peter), PhD, Zhpping Ye

Rebecca K Olin's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-04-29
July, 2013 EIR Stallergenes - EIR, 2013-07-02
September, 2007 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2007-09-21
July, 2013 FDA 483 CENEXI - Form 483, 2013-07-05
April, 2002 EIR AbbVie Inc. - EIR, 2002-04-25
July, 2013 FDA 483 Stallergenes - Form 483, 2013-07-02
April, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-04-25
May, 2011 FDA 483 GlaxoSmithKline Biologicals - Form 483, 2011-05-05
April, 2011 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2011-04-01
September, 2010 FDA 483 CAF-DAF scrl - Form 483, 2010-09-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more